Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
BeOne Medicines
National Institutes of Health Clinical Center (CC)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Gilead Sciences
Seagen Inc.
Genmab
PrECOG, LLC.
Merck Sharp & Dohme LLC
AstraZeneca
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Mirati Therapeutics Inc.
Eli Lilly and Company
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Incyte Corporation
Revolution Medicines, Inc.
Qilu Pharmaceutical Co., Ltd.
Hoffmann-La Roche
Bristol-Myers Squibb
AstraZeneca
AstraZeneca
AbbVie
UNICANCER
Pfizer
Bristol-Myers Squibb
AstraZeneca
Regeneron Pharmaceuticals
AbbVie
Thomas Jefferson University
Hoffmann-La Roche
Daiichi Sankyo
Fudan University
Allist Pharmaceuticals, Inc.
AstraZeneca
Gilead Sciences
BeOne Medicines
Revolution Medicines, Inc.
University of Vermont
Fundación GECP
Merck Sharp & Dohme LLC
Hoffmann-La Roche
GlaxoSmithKline